American Oncology Network Inc
OTC:AONC
American Oncology Network Inc
OTC:AONC
Price:
11.5
USD
Market Closed
Market Cap:
$540m
Income Statement
Earnings Waterfall
American Oncology Network Inc
American Oncology Network Inc
Income Statement
American Oncology Network Inc
American Oncology Network Inc
Currency: USD
| Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||
| Interest Expense |
1
|
0
|
1
|
2
|
3
|
4
|
5
|
6
|
6
|
7
|
7
|
7
|
7
|
|
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
336
N/A
|
1 279
+280%
|
1 025
-20%
|
1 459
+42%
|
1 593
+9%
|
1 759
+10%
|
|
| Gross Profit | ||||||||||||||
| Cost of Revenue |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(311)
|
(1 196)
|
(981)
|
(1 386)
|
(1 509)
|
(1 642)
|
|
| Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
25
N/A
|
83
+226%
|
43
-48%
|
73
+68%
|
84
+15%
|
118
+40%
|
|
| Operating Income | ||||||||||||||
| Operating Expenses |
(3)
|
(2)
|
(2)
|
(2)
|
(5)
|
(3)
|
(4)
|
(29)
|
(101)
|
(83)
|
(118)
|
(128)
|
(134)
|
|
| Selling, General & Administrative |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(25)
|
(94)
|
(81)
|
(118)
|
(128)
|
(126)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(7)
|
0
|
0
|
0
|
(8)
|
|
| Other Operating Expenses |
(2)
|
(2)
|
(2)
|
(2)
|
(5)
|
(3)
|
(4)
|
(3)
|
0
|
0
|
0
|
0
|
0
|
|
| Operating Income |
(3)
N/A
|
(2)
+44%
|
(2)
-3%
|
(2)
-30%
|
(5)
-96%
|
(3)
+34%
|
(4)
-39%
|
(3)
+27%
|
(18)
-462%
|
(39)
-120%
|
(45)
-15%
|
(44)
+3%
|
(16)
+63%
|
|
| Pre-Tax Income | ||||||||||||||
| Interest Income Expense |
0
|
0
|
0
|
2
|
5
|
7
|
7
|
4
|
(5)
|
(3)
|
(4)
|
(4)
|
(4)
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(25)
|
(31)
|
(26)
|
(27)
|
(3)
|
(1)
|
|
| Total Other Income |
20
|
14
|
10
|
9
|
23
|
4
|
2
|
(4)
|
(8)
|
(6)
|
(0)
|
1
|
(3)
|
|
| Pre-Tax Income |
17
N/A
|
12
-27%
|
8
-34%
|
9
+6%
|
23
+169%
|
9
-63%
|
5
-41%
|
(28)
N/A
|
(63)
-127%
|
(75)
-20%
|
(77)
-2%
|
(49)
+36%
|
(25)
+50%
|
|
| Net Income | ||||||||||||||
| Tax Provision |
0
|
0
|
(0)
|
(0)
|
(1)
|
(1)
|
(2)
|
(1)
|
(0)
|
(3)
|
(3)
|
(3)
|
(2)
|
|
| Income from Continuing Operations |
17
|
12
|
8
|
8
|
21
|
7
|
4
|
(29)
|
(63)
|
(78)
|
(79)
|
(52)
|
(27)
|
|
| Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
27
|
58
|
63
|
70
|
43
|
23
|
|
| Equity Earnings Affiliates |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
(0)
|
0
|
0
|
|
| Net Income (Common) |
17
N/A
|
12
-27%
|
8
-35%
|
8
+2%
|
21
+156%
|
7
-66%
|
4
-50%
|
(4)
N/A
|
(9)
-140%
|
(19)
-110%
|
(16)
+16%
|
(15)
+9%
|
(10)
+35%
|
|
| EPS (Diluted) |
0.48
N/A
|
0.29
-40%
|
0.19
-34%
|
0.19
N/A
|
0.51
+168%
|
0.7
+37%
|
0.35
-50%
|
-0.39
N/A
|
-1.36
-249%
|
-1.84
-35%
|
-0.43
+77%
|
-1.09
-153%
|
-0.69
+37%
|
|
Switch to:
Switch to:
See Also
Discover More
